GlassScriptPhysician profile
David James Tobey
NPI 1528324381
$1,888.19
in general payments reported to CMS, 2019-2025
10 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2020: $26.18 · 2021: $82.56 · 2022: $76.54 · 2023: $183 · 2024: $158 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $989.68 | 2019 | |
| Smith+Nephew, INC. | $205.01 | 2022-2025 | Grafix Pl, Collagenase Santyl |
| Medtronic Vascular, INC. | $159.50 | 2019 | |
| Medtronic, INC. | $156.17 | 2021-2025 | Venaseal |
| Novartis Pharmaceuticals Corporation | $138.33 | 2020-2023 | |
| Organogenesis INC. | $124.99 | 2023 | Puraply Antimicrobial |
| W. L. Gore & Associates, INC. | $67.37 | 2025 | Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Integra Lifesciences Corporation | $23.59 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Janssen Biotech, INC. | $21.59 | 2024 | Xarelto |
| Merit Medical Systems INC | $1.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tobey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.